Luciana Romão

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Ciências Biomédicas

Departamento:

Instituto de Ciências Biomédicas/ICB

ORCID:

não disponível no Lattes


Formação:
  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2008 - 2009
  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2007 - 2008
  • Universidade Federal do Rio de Janeiro

    Ciências Morfológicas | Doutorado | 2003 - 2007
  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas Modalidade Médica | Graduação | 1998 - 2003
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(98.18% artigos com DOI)

Titulo DOI Ano
Bacteriophage P22 Capsid as a Pluripotent Nanotechnology Tool 10.3390/v15020516 2023
SARS-CoV-2 spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID syndrome in mice 10.1016/j.celrep.2023.112189 2023
Physical exercise influences astrocytes in the striatum of a Parkinson?s disease male mouse model 10.1016/j.neulet.2022.136466 2022
Centromere protein J is overexpressed in human glioblastoma and promotes cell proliferation and migration. 10.1111/jnc.15660 2022
The dopamine receptor agonist apomorphine stabilizes neurotoxic α-synuclein oligomers 10.1002/1873-3468.14263 2022
The multiple functions of PrPC in physiological, cancer, and neurodegenerative contexts 10.1007/s00109-022-02245-9 2022
GLIPR1 and SPARC Expression Profile Reveals a Signature Associated with Prostate Cancer Brain Metastasis 10.1016/j.mce.2021.111230 2021
Common Dysregulation of Innate Immunity Pathways in Human Primary Astrocytes Infected With Chikungunya, Mayaro, Oropouche, and Zika Viruses 10.3389/fcimb.2021.641261 2021
Physical exercise increases the production of tyrosine hydroxylase and CDNF in the spinal cord of a Parkinson?s disease mouse model 10.1016/j.neulet.2021.136089 2021
Assessing the antiproliferative effect of biogenic silver chloride nanoparticles on glioblastoma cell lines by quantitative image-based analysis 10.1049/nbt2.12038 2021
Membrane Elastic Properties During Neural Precursor Cell Differentiation 10.3390/cells9061323 2020
Astrocyte glutamate transporters are increased in an early sporadic model of synucleinopathy 10.1016/j.neuint.2020.104758 2020
In Vitro Protective Action of Monomeric and Fibrillar α-Synuclein on Neuronal Cells Exposed to the Dopaminergic Toxins Salsolinol and DOPAL 10.1021/acschemneuro.0c00527 2020
Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells 10.1016/j.bioorg.2018.10.003 2019
α-synuclein oligomers enhance astrocyte-induced synapse formation through TGF -β1 signaling in a Parkinson's disease model 10.1111/jnc.14710 2019
Diosmin induces caspase-dependent apoptosis in human glioblastoma cells 10.1590/0001-3765201920191031 2019
Guanosine and GMP increase the number of granular cerebellar neurons in culture: dependence on adenosine A2A and ionotropic glutamate receptors 10.1007/s11302-019-09677-y 2019
Conjugation with polyamines enhances the antitumor activity of naphthoquinones against human glioblastoma cells 10.1097/cad.0000000000000619 2018
Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response 10.1007/s12035-018-0895-1 2018
GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling 10.1007/s12035-018-1150-5 2018
In vitro neurotoxicity of salsolinol is attenuated by the presynaptic protein α-synuclein 10.1016/j.bbagen.2018.08.022 2018
Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synuclein 10.1016/j.bbrc.2018.09.111 2018
Silver/silver chloride nanoparticles inhibit the proliferation of human glioblastoma cells 10.1007/s10616-018-0253-1 2018
Derivation of Functional Human Astrocytes from Cerebral Organoids 10.1038/srep45091 2017
Brain infusion of ?-synuclein oligomers induces motor and non-motor Parkinson?s disease-like symptoms in mice 10.1016/j.bbr.2017.06.047 2017
An ortho-Iminoquinone Compound Reacts with Lysine Inhibiting Aggregation while Remodeling Mature Amyloid Fibrils. 10.1021/acschemneuro.7b00017 2017
Rheological properties of cells measured by optical tweezers 10.1186/s13628-016-0031-4 2016
The Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role Against α-Synuclein Oligomers 10.1074/jbc.m115.662254 2015
Connective-Tissue Growth Factor (CTGF/CCN2) Induces Astrogenesis and Fibronectin Expression of Embryonic Neural Cells In Vitro 10.1371/journal.pone.0133689 2015
Astrocyte transforming growth factor beta 1 promotes inhibitory synapse formation via CaM kinase II signaling 10.1002/glia.22713 2014
UV-induced selective oxidation of Met5 to Met-sulfoxide leads to the formation of neurotoxic fibril-incompetent α-synuclein oligomers 10.3109/13506129.2014.912208 2014
Glioblastoma cells inhibit astrocytic p53-expression favoring cancer malignancy 10.1038/oncsis.2014.36 2014
The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model 10.1186/1471-2407-14-923 2014
Equinatoxin II Potentiates Temozolomide- and Etoposide-Induced Glioblastoma Cell Death 10.2174/1568026611212190006 2013
CONNECTIVE TISSUE GROWTH FACTOR (CTGF/CCN2) IS NEGATIVELY REGULATED DURING NEURON-GLIOBLASTOMA INTERACTION. 10.1371/journal.pone.0055605 2013
Membrane Elastic Properties and Cell Function 10.1371/journal.pone.0067708 2013
Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis 10.1038/cddis.2013.325 2013
Microglial stress inducible protein 1 promotes proliferation and migration in human glioblastoma cells 10.1016/j.neuroscience.2011.10.025 2012
Glioblastoma: Therapeutic challenges, what lies ahead 10.1016/j.bbcan.2012.05.004 2012
Astrocyte-induced synaptogenesis is mediated by transforming growth factor beta signaling through modulation of D-serine levels in cerebral cortex neurons 10.1074/jbc.M112.380824 2012
The Anti-Parkinsonian Drug Selegiline Delays the Nucleation Phase of ?-Synuclein Aggregation Leading to the Formation of Nontoxic Species 10.1016/j.jmb.2010.10.027 2011
NEURON-GLIA SIGNALING: IMPLICATIONS FOR SYNAPSE DEVELOPMENT AND ASTROCYTE 10.1016/j.lfs.2011.04.005 2011
Homocysteine induces cytoskeletal remodeling and production of reactive oxygen species in cultured cortical astrocytes 10.1016/j.brainres.2010.07.071 2010
CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors. 10.1186/1471-2407-10-66 2010
Effect of thyroid hormone T3 on Myosin-Va expression in the central nervous system. 10.1016/j.brainres.2009.03.070 2009
Glutamate activates GFAP gene promoter from cultured astrocytes through TGF-1 pathways 10.1111/j.1471-4159.2008.05428.x 2008
New highly fluorescent biolabels based on II-VI semiconductor hybrid organic-inorganic nanostructures for bioimaging 10.1016/j.apsusc.2008.07.024 2008
Functional conversion of astrocytes into neural progenitor-like cells upon prolonged exposure to Transforming Growth Factor alpha 10.1038/sj.onc.1210071 2007
Dopamine Affects the Stability, Hydration, and Packing of Protofibrils and Fibrils of the Wild Type and Variants of ?-Synuclein 10.1021/bi061871+ 2007
Guanine Derivatives Modulate Extracellular Matrix Proteins Organization 10.1002/jnr.21332 2007
Interactive properties of human glioblastoma cells with brain neurons culture and neuronal modulation of glial laminin organization. 10.1111/j.1432-0436.2006.00090.x 2006
Quantum dots as fluorescent bio-labels in cancer diagnostic 10.1002/pssc.200671526 2006
Emerging roles for TGFb1 in nervous system development 10.1016/j.ijdevneu.2005.04.001 2005
Trophic effects of GMP and guanosine on cerebellar neuron-astrocyte coculture. 2004
Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions 10.1111/j.1460-9568.2004.03249.x 2004
Eventos:

(6.67% eventos com DOI)

Titulo DOI Ano
ESTUDO DE CONFIABILIDADE DO TESTE DA HASTE EM MODELO ANIMAL DA DOENÇA DE PARKINSON BILATERAL 2017
INTERAÇÃO NEURÔNIO-MICROGLIA NO CONTEXTO DA DOENÇA DE PARKINSON: O PAPEL DA CITOCINA CCL21 2017
UTILIZAÇÃO DE GAIOLAS PROTEICAS DERIVADAS DO BATERIÓFAGO P22 COMO NANOCARREADORES DE DROGAS PARA DOENÇAS DO SISTEMA NERVOSO CENTRAL 2017
PAPEL DAS VIAS YAP/TAZ E TGF-Β1/SMAD2 NA DIFERENCIAÇÃO DE CÉLULAS TRONCO TUMORAIS DE GLIOBLASTOMA 2017
ANáLISE DA EXPRESSãO DE CCL21 EM NEURôNIOS DOPAMINéRGICOS TRATADOS COM 3,4 DIHIDROXIFENILACETALDEINO (DOPAL) ? MODELO DA DP IN VITRO 2017
O PAPEL DOS ASTRóCITOS NO MODELO DE DOENçA DE PARKINSON INDUZIDA POR DOPAL (3,4- DIIDROXIFENILACETALDEíDO) 2017
A SUBREGULAÇÃO DA PROTEÍNA CENPJ REDUZ A MIGRAÇÃO E PROLIFERAÇÃO CELULAR EM GLIOBLASTOMA 2017
O PAPEL ANTITUMORAL DA CENTRATERINA EM CéLULAS DE GLIOBLASTOMA 2017
NOVOS COMPOSTOS COM POTENCIAL TERAPÊUTICO PARA O TRATAMENTO DE GLIOBLASTOMA 2016
CINQUENTA BILHõES DE CHANCES PARA CURAR DOENçAS DO SISTEMA NERVOSO CENTRAL: UTILIZAçãO DE GAIOLAS PROTEICAS DERIVADAS DO BACTERIóFAGO P22 PARA ENCAPSULAMENTO E DIRECIONAMENTO DE COMPOSTOS PARA CéLULAS GLIAIS 2016
ANáLISE DA EXPRESSãO DE CCL21 EM NEURôNIOS DOPAMINéRGICOS TRATADOS COM ALFA-SINUCLEíNA. 2016
MODELO EXPERIMENTAL DA DOENÇA DE PARKINSON ATRAVÉS DE INJEÇÕES INTRAESTRIATAIS UNILATERAIS DE OLIGÔMEROS DE ALFA-SINUCLEÍNA EM CAMUNDONGOS 2016
EFEITOS NEUROPROTETORES DAS CéLULAS GLIAIS NA DOENçA DE PARKINSON 2016
CARACTERIZAçãO DE CíLIO PRIMáRIO EM GLIOBLASTOMA ATRAVéS DA EXPRESSãO DA PROTEíNA CENPJ 2016
<title>Application of colloidal semiconductor quantum dots as fluorescent labels for diagnosis of brain glial cancer</title> 10.1117/12.646866 2006
Publicações:
Minha Rede: